We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




European Commission Funds Development of Patient-Friendly Endoscopy System

By Labmedica staff writers
Posted on 09 Feb 2007
A group of nine European companies and universities have been awarded a multimillion-euro research contract to develop a patient-friendly, highly sensitive screening system for the detection of early cancer and pre-cancerous conditions in the gastrointestinal tract. More...
The Nano-based capsule-Endoscopy with Molecular Imaging and Optical biopsy (NEMO) project will be funded under the auspices of the European Commission of the Sixth EU Framework Program of Research and Technological Development (FP6 commission).

The NEMO project is based on the Given Imaging (Yoqneam, Israel) PillCam video capsule. This device comprises a disposable, miniature video camera contained in a capsule, which is ingested by the patient, a sensor array, data recorder, and dedicated software.

Several of the research partners are engineering firms whose task will be to upgrade and enhance the electronic and mechanical systems built into the capsule. Another aspect of the project is the insertion or attachment of an immunodiagnostic test to the capsule that will allow real-time diagnosis of lesions spotted by capsule video. Novamed Ltd. (Jerusalem, Israel) is leading this section of the project in cooperation with hospitals and clinical laboratories in Germany and Italy.

We are proud to advance our research in the bio-sensing field with such leading research and industrial organizations,” said Dr. Elisha Rabinovitz, chief scientist of Given Imaging. "This project further exemplifies Given's commitment to develop new and innovative solutions to help physicians treat their patients and could represent a revolutionary platform of biopsy-free procedures.”




Related Links:
Given Imaging
Novamed Ltd.

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.